10x Genomics, Inc. — Director's Dealing 2019

Sep 12, 2019

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: 10x Genomics, Inc. (TXG)
CIK: 0001770787
Period of Report: 2019-09-11

Reporting Person: Kosaraju Sridhar (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Class B Common Stock	10833	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$11.48	2029-05-10	Class B Common Stock (119167)		Direct

Footnotes

F1: Each share of Class B Common Stock shall be reclassified into one share of Class A Common Stock immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock.

F2: These shares are held by the Kosaraju Family Trust dated June 21, 2014, of which the Reporting Person is trustee.

F3: This option, originally for 130,000 shares, of which 10,833 have been exercised, vested as to one forty-eighth of the shares on April 29, 2019, and one forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date. This option may be exercised prior to vesting, subject to the Issuer's right to repurchase unvested shares.